For in-vitro research use only · Not for human consumption · Not medical advice
The Growth Hormone Amplifier
Instead of injecting synthetic growth hormone (which shuts down your body's own production), CJC-1295 tells your pituitary gland to release more of what it already has — naturally.
Molecular Weight
3,367.97 Da
CAS Number
863288-34-0
Amino Acids
30 residues
In Plain English
Your pituitary gland is like a warehouse full of growth hormone, and your body has a natural messenger — called GHRH (Growth Hormone Releasing Hormone) — that tells the warehouse when to ship. CJC-1295 is a modified version of that messenger, engineered to last longer in the body and deliver a stronger signal.
Here's why that matters: as you age, the warehouse doesn't run out of stock. Your pituitary still has growth hormone. What declines is the signal strength — your body sends fewer and weaker "ship" messages. CJC-1295 is studied for its ability to restore that signaling, prompting the pituitary to release GH in natural pulsatile patterns rather than the flat, constant levels you'd get from synthetic GH injection.
The "pulsatile" part is crucial. Your body is designed to receive growth hormone in waves — a burst, then a break, then another burst. This pattern preserves the body's feedback mechanisms and receptor sensitivity. Synthetic GH floods the system constantly, which can downregulate the very receptors you're trying to stimulate.
Researchers often study CJC-1295 paired with Ipamorelin because they work through different receptors on the pituitary, amplifying the signal through two separate pathways without the cortisol and hunger side effects seen with older GH secretagogues.
Plain English: CJC-1295 is a longer-lasting version of your body's own "release growth hormone" signal. It tells the pituitary to ship what it already has, in the natural wave pattern your body expects.
How It Works
CJC-1295 binds to the GHRH receptor on pituitary somatotroph cells — the exact same receptor your body's natural GHRH uses. But due to amino acid substitutions, it resists enzymatic breakdown, maintaining the signal far longer than the natural hormone.
Unlike exogenous GH, CJC-1295 preserves the body's natural pulsatile secretion pattern. The pituitary still responds to normal feedback loops, releasing GH in bursts that match circadian rhythm — especially the critical nocturnal pulse during deep sleep.
The GH released by CJC-1295 stimulation travels to the liver and other tissues, where it triggers production of IGF-1 (Insulin-like Growth Factor 1) — the molecule that actually drives much of GH's anabolic, repair, and metabolic effects throughout the body.
Evidence
GH Elevation
Clinical studies have demonstrated that CJC-1295 (with DAC) produced sustained elevations in GH levels for 6+ days after a single administration, with IGF-1 levels remaining elevated for 9-11 days — far longer than natural GHRH.
Takeaway: CJC-1295's modified structure gives it a dramatically extended half-life, meaning less frequent administration in research settings.
Body Composition
Research on GHRH analogs has shown improvements in body composition markers, including increases in lean body mass and decreases in trunk fat percentage, consistent with elevated GH and IGF-1 signaling.
Takeaway: By restoring GH pulsatility, CJC-1295 may support the body's natural metabolic and anabolic processes.
Sleep Quality
Growth hormone secretion is tightly linked to slow-wave (deep) sleep. Research suggests that GHRH analogs like CJC-1295 may amplify the nocturnal GH pulse, potentially enhancing the restorative quality of sleep.
Takeaway: Better GH pulsing during sleep may create a positive feedback loop — deeper sleep means more GH, and more GH means deeper sleep.
Preserved Feedback
Unlike exogenous GH administration, CJC-1295 works with the body's existing feedback mechanisms. The pituitary remains responsive to somatostatin (the "stop" signal), preventing the runaway GH elevation seen with synthetic GH.
Takeaway: CJC-1295 amplifies the system rather than overriding it — the body's safety checks stay intact.
AminoVita Research Compound
$49.99
99%+ purity · Third-party tested · 5 mg
View ProductSubscribe & Save 10% — Free shipping on every order
Further Reading
Mechanism Deep Dive
How CJC-1295 binds the GHRH receptor, why its modified structure extends half-life, and what the clinical data shows about GH and IGF-1 elevation.
Wellness Science
The connection between growth hormone pulsing, slow-wave sleep, and why waking at 3 AM might signal a deeper metabolic issue.
FAQ
DAC (Drug Affinity Complex) is a modification that extends CJC-1295's half-life by binding to albumin in the blood. The DAC version produces sustained GH elevation over days, while the non-DAC version (sometimes called Mod GRF 1-29) produces shorter, more acute GH pulses that more closely mimic natural secretion patterns.
Exogenous GH provides a constant, non-physiological level of growth hormone that suppresses the pituitary's own production over time. CJC-1295 works through the pituitary, preserving natural pulsatile patterns and feedback mechanisms. The body's "brakes" (somatostatin) still work, preventing excess.
Your body naturally releases GH in bursts (pulses) throughout the day, with the largest pulse during deep sleep. This on-off pattern is essential for maintaining receptor sensitivity — if receptors are exposed to constant GH, they downregulate and stop responding. Pulsatile release keeps the system responsive and effective.
Both are GHRH analogs but with different structures. CJC-1295 is a modified 30-amino-acid fragment with amino acid substitutions for stability. Tesamorelin is the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid modification. Tesamorelin has received regulatory approval for a specific indication, making it the most validated GHRH analog.
Not sure where to start? Browse compounds by research goal and find the right combination for your objectives.
Browse Catalog